Sylvie Julien

2.2k total citations
60 papers, 1.6k citations indexed

About

Sylvie Julien is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sylvie Julien has authored 60 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Ophthalmology, 34 papers in Molecular Biology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sylvie Julien's work include Retinal Diseases and Treatments (32 papers), Retinal Development and Disorders (29 papers) and Glaucoma and retinal disorders (12 papers). Sylvie Julien is often cited by papers focused on Retinal Diseases and Treatments (32 papers), Retinal Development and Disorders (29 papers) and Glaucoma and retinal disorders (12 papers). Sylvie Julien collaborates with scholars based in Germany, France and India. Sylvie Julien's co-authors include Ulrich Schraermeyer, Antje Biesemeier, Tatjana Taubitz, Peter Heiduschka, Karl Ulrich Bartz‐Schmidt, Focke Ziemssen, Swaantje Peters, Efdal Yoeruek, Sabine Hofmeister and Alexander Tschulakow and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Biomaterials.

In The Last Decade

Sylvie Julien

57 papers receiving 1.6k citations

Peers

Sylvie Julien
Weiyong Shen Australia
Shu Kachi Japan
George N. Lambrou Switzerland
Kameran Lashkari United States
Weiyong Shen Australia
Sylvie Julien
Citations per year, relative to Sylvie Julien Sylvie Julien (= 1×) peers Weiyong Shen

Countries citing papers authored by Sylvie Julien

Since Specialization
Citations

This map shows the geographic impact of Sylvie Julien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Julien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Julien more than expected).

Fields of papers citing papers by Sylvie Julien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Julien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Julien. The network helps show where Sylvie Julien may publish in the future.

Co-authorship network of co-authors of Sylvie Julien

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Julien. A scholar is included among the top collaborators of Sylvie Julien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Julien. Sylvie Julien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Molinier, O., J. Pinsolle, Sebastian Schneider, et al.. (2024). COVID-19 among lung cancer patients: Data from a real-life prospective French multicentric study. Respiratory Medicine and Research. 86. 101093–101093. 1 indexed citations
3.
Fang, Yuan, Tatjana Taubitz, Alexander Tschulakow, et al.. (2022). Removal of RPE lipofuscin results in rescue from retinal degeneration in a mouse model of advanced Stargardt disease: Role of reactive oxygen species. Free Radical Biology and Medicine. 182. 132–149. 14 indexed citations
4.
Xi, Lei, et al.. (2022). Pigment Epithelium‐Derived Factor Protects Retinal Neural Cells and Prevents Pathological Angiogenesis in an Ex Vivo Ischemia Model. Oxidative Medicine and Cellular Longevity. 2022(1). 4199394–4199394. 4 indexed citations
6.
Julien, Sylvie, et al.. (2019). Stabilization and supporting blood vessel growth as a new concept to treat wet AMD. Investigative Ophthalmology & Visual Science. 60(9). 366–366. 1 indexed citations
7.
Taubitz, Tatjana, et al.. (2017). Testing a new pharmacological therapy approach for the removal of lipofuscin in vitro: results from a newly established culture of aged primary Stargardt mouse model RPE cells and aged primary human RPE cells. Investigative Ophthalmology & Visual Science. 58(8). 257–257. 1 indexed citations
8.
9.
Tschulakow, Alexander, Ulrich Schraermeyer, H. Peter Rodemann, & Sylvie Julien. (2016). Establishment of a novel retinoblastoma (Rb) nude mouse model by intravitreal injection of human Rb Y79 cells – comparison of in vivo analysis versus histological follow up. Biology Open. 5(11). 1625–1630. 10 indexed citations
10.
Biesemeier, Antje, Sylvie Julien, & Ulrich Schraermeyer. (2014). Choroidal neovascularization can help photoreceptors to survive in late AMD.. Investigative Ophthalmology & Visual Science. 55(13). 1186–1186.
11.
Tschulakow, Alexander, et al.. (2014). Effects of a Single Intravitreal Injection of Aflibercept and Ranibizumab on Glomeruli of Monkeys. PLoS ONE. 9(11). e113701–e113701. 27 indexed citations
12.
Julien, Sylvie & Ulrich Schraermeyer. (2012). Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys. Neurobiology of Aging. 33(10). 2390–2397. 42 indexed citations
13.
Heiduschka, Peter, et al.. (2010). Rescue of Degenerating Photoreceptors in the RCS Rat by an AAV2/4-RPE65-Mertk Vector. Investigative Ophthalmology & Visual Science. 51(13). 5192–5192. 1 indexed citations
14.
Julien, Sylvie, Antje Biesemeier, Peter Heiduschka, et al.. (2010). Lipofuscin Can Be Eliminated From Retinal Pigment Epithelium After Drug Treatment. Investigative Ophthalmology & Visual Science. 51(13). 481–481. 1 indexed citations
15.
Sorce, Silvia, Jérôme Bonnefont, Sylvie Julien, et al.. (2010). Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5. British Journal of Pharmacology. 160(2). 311–321. 57 indexed citations
16.
Koss, Michael, Sylvie Julien, Tomasz Chorągiewicz, et al.. (2009). Effects of Combined- vs. Monotherapy in CNV-Induced Albino Rabbits. Investigative Ophthalmology & Visual Science. 50(13). 743–743. 1 indexed citations
17.
Schraermeyer, Ulrich, Sigrid Henke‐Fahle, Salvatore Grisanti, et al.. (2006). Evidence For Transport Of Bevacizumab (Avastin) Through The Retina By Muller Cells In Rabbits. Investigative Ophthalmology & Visual Science. 47(13). 4169–4169. 2 indexed citations
18.
Julien, Sylvie, Peter Heiduschka, Salvatore Grisanti, et al.. (2006). Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells. British Journal of Ophthalmology. 91(6). 827–831. 47 indexed citations
19.
Julien, Sylvie, Pauline Soulas‐Sprauel, Jean-Claude Garaud, Thierry Martin, & Jean‐Louis Pasquali. (2002). B Cell Positive Selection by Soluble Self-Antigen. The Journal of Immunology. 169(8). 4198–4204. 44 indexed citations
20.
Soulas‐Sprauel, Pauline, Sylvie Julien, Anne‐Marie Knapp, et al.. (2002). A role for membrane IgD in the tolerance of pathological human rheumatoid factor B cells. European Journal of Immunology. 32(9). 2623–2634. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026